JNK New use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases

摘要

The present invention relates to the use of protein kinase inhibitors, and more particularly to the use of inhibitors of protein kinase c-Jun amino terminal kinase, JNK inhibitor sequences, chimeric peptides or chimeric peptides to treat various diseases or disorders strongly associated with JNK signaling As well as the use of pharmaceutical compositions containing them.